🚨ICYMI: Cochrane #hypertension review: #Riboflavin supplements for blood pressure lowering in adults www.cochranelibrary.com/cdsr/doi/10.... 🤔 Very uncertain evidence for effect of riboflavin on #bloodpressure 🎯 Large, well‐conducted trials needed #SystematicReviews #CochraneEvidence

🚨ICYMI: Cochrane Review update Pharmacotherapy for mild #hypertension www.cochranelibrary.com/cdsr/doi/10.... In ppl w/ mildly elevated #BloodPressure (BP) w/out cardiovascular disease or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview

🚨ICYMI: Cochrane Review update Pharmacotherapy for mild #hypertension www.cochranelibrary.com/cdsr/doi/10.... In ppl w/ mildly elevated #BloodPressure (BP) w/out cardiovascular disease or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview

🚨ICYMI - Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/1465... "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

🚨ICYMI: Cochrane Review update Pharmacotherapy for mild #hypertension www.cochranelibrary.com/cdsr/doi/10.... In ppl w/ mildly elevated #BloodPressure (BP) w/out cardiovascular disease or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview

🚨ICYMI: Cochrane #hypertension review: #Riboflavin supplements for blood pressure lowering in adults www.cochranelibrary.com/cdsr/doi/10.... 🤔 Very uncertain evidence for effect of riboflavin on #bloodpressure 🎯 Large, well‐conducted trials needed #SystematicReviews #CochraneEvidence

🚨@cochrane.org Review update Pharmacotherapy for mild #hypertension www.cochranelibrary.com/cdsr/doi/10.... In ppl w/ mildly elevated #BloodPressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview

🚨ICYMI: Cochrane #hypertension review: #Riboflavin supplements for blood pressure lowering in adults www.cochranelibrary.com/cdsr/doi/10.... 🤔 Very uncertain evidence for effect of riboflavin on #bloodpressure 🎯 Large, well‐conducted trials needed #SystematicReviews #CochraneEvidence

🚨ICYMI - Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/1465... "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

🚨ICYMI - Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/1465... "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

🌍 Antihypertensives are among the commonly prescribed medications globally. Read about a recently-published systematic review & meta-analysis on #deprescribing antihypertensive medications in older people, conducted together with our collaborators here: buff.ly/CPznF05

🆕 Cochrane #hypertension review: #Riboflavin supplements for blood pressure lowering in adults www.cochranelibrary.com/cdsr/doi/10.... 🤔 Very uncertain evidence for effect of riboflavin on #bloodpressure 🎯 Large, well‐conducted trials needed #SystematicReviews #CochraneEvidence

Too good to be true? Spotting problematic trials in systematic reviews | Online 🗓️26 February This interactive webinar will introduce the INSPECT-SR tool by way of application to a published clinical trial. 🔗Register here: evidencesynthesisireland.ie/conference/w...

🚨ICYMI - Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/1465... "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

🆕Review update🆕 Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10.... In people with mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview

🆕 @cochrane.org Review update 🆕 Pharmacotherapy for mild hypertension www.cochranelibrary.com/cdsr/doi/10.... In ppl w/ mildly elevated blood pressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview

Clearer, more consistent Cochrane reviews are coming. From mid-November, we’re updating reporting formats to make reviews easier to use, more accessible, and more impactful. 🔗 www.cochrane.org/about-us/new...

Too good to be true? Spotting problematic trials in systematic reviews | Online 🗓️ 26 February This interactive webinar will introduce the INSPECT-SR tool by way of application to a published clinical trial. 🔗 evidencesynthesisireland.ie/conference/w...

Getting involved in health research reviews: a course for the public | Online 🗓️ 15 September Are you a patient, caregiver, or member of the public interested in contributing to health research? This 6-week, self-paced course from Cochrane Ireland is for you. 🔗 www.eventbrite.ie/e/getting-in...

📣 We're rounding up a few dates for your diary. Discover these events being run by our global network of Cochrane Groups – a thread 🧵

ICYMI - Cochrane #SystematicReview 🎺 Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/1465... #CochraneEvidence #Blogshot

🚨ICYMI - Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/1465... "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

Also check out our complementary #deprescribing resources to reduce potentially inappropriate medications found here: deprescribing.org/resources/de...

🚨ICYMI - Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/1465... "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

🆕 We've published a new Cochrane #SystematicReview protocol: Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists doi.org/10.1002/1465...

SR & MA findings: very few (<10%) clinical trials report adverse drug withdrawal event (ADWE) following #deprescribing, and reporting methods are inconsistent. Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...

🚨 ICYMI - TI #BestEvidence webinar: Dr. Josh Levin compares #PhysicalActivity to drugs for important clinical outcomes ti.ubc.ca/drugevidence24 #DrugEvidence24 #exercise #MedEd

ICYMI: #BestEvidence webinar recording Debunking some of the hype in #hypertension ti.ubc.ca/drugevidence24 Dr. James Wright summarizes latest evidence on #antihypertensives ⏰ chronotherapy 💊 first line tx 🎯 BP targets ⚠️ tx efficacy + safety #DrugEvidence24 #MedEd #medsafety

🚨Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/1465... "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

🧵 #ExercisePrescriptions 1/5 The TI’s Dr. Josh Levin asks: Clinicians, can you help your patients be more active? 🏃🏾‍♀️🏊🏾‍♂️ 🚶🏾‍♂️ 👉🏾Watch Dr. Levin’s presentation: www.youtube.com/watch?v=G5he... #Exercise #prescribing #ExerciseRx

🆕 Cochrane #SystematicReview 🆕 Effect of adrenergic agonist oral #decongestants on blood pressure: www.cochranelibrary.com/cdsr/doi/10.... #CochraneEvidence #blogshot #bloodpressure

🆕 Cochrane #SystematicReview 🆕 Effect of #amphetamines on blood pressure: www.cochranelibrary.com/cdsr/doi/10.... #CochraneEvidence #blogshot #bloodpressure

ICYMI - Cochrane #SystematicReview 🎺 Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/1465... #CochraneEvidence #Blogshot

🚨ICYMI - Cochrane #SystematicReview Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/1465... #CochraneEvidence #Blogshot

Cochrane #SystematicReview 🎺 Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/14651858.CD012570.pub2 #CochraneEvidence #Blogshot

#BestEvidence webinar recording Debunking some of the hype in #Hypertension ti.ubc.ca/drugevidence24 Dr. James Wright summarizes latest evidence on #antihypertensives: ⏰ chronotherapy 💊 first line tx 🎯 blood pressure targets ⚠️ treatment efficacy + safety #drugevidence24 #meded #medsafety

🎺 Cochrane #SystematicReview 🚨 Renin inhibitors versus angiotensin receptor blockers for primary #hypertension tinyurl.com/renin-arb-htn #CochraneEvidence #Blogshot @drotte.medsky.social @ciprian-jauca.bsky.social @amtejani.bsky.social

🎺 Cochrane #SystematicReview 🚨 Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/1465... #CochraneEvidence #Blogshot

🆕 Cochrane #SystematicReview 🎺 Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/1465... #CochraneEvidence

🆕 #BestEvidence webinar recording Debunking some of the hype in #Hypertension ti.ubc.ca/drugevidence24 Dr. James Wright summarizes latest evidence on #antihypertensives: ⏰ chronotherapy 💊 first line tx 🎯 blood pressure targets ⚠️ treatment efficacy + safety #drugevidence24 #meded #medsafety

ICYMI - For people with high #bloodpressure (BP) & chronic renal disease, evidence does NOT support lower than standard BP targets 🎯 Our #Cochrane review looks at evidence from 6 trials involving 7,348 participants: tinyurl.com/BP-targets-r... #SystematicReview #hypertension #medsky #pharmsky

ICYMI - hypertension #systematicreview Our Cochrane Library review on evening vs morning dosing considers evidence from 25 studies that randomised more than 3,000 people: tiny.cc/pm-am-htn #researchsky #prescribing #HighBloodPressure #medsky

🎺 For people with high #bloodpressure (BP) & chronic renal disease, evidence does NOT support lower than standard BP targets 🎯 Our #Cochrane systematic review looks at evidence from 6 trials involving 7,348 participants: tinyurl.com/BP-targets-r... #SystematicReview #hypertension